Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-134950
Filing Date
2018-04-26
Accepted
2018-04-26 16:38:01
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d570679d424b5.htm 424B5 478720
2 GRAPHIC g570679g13d40.jpg GRAPHIC 162086
3 GRAPHIC g570679g76n76.jpg GRAPHIC 45522
4 GRAPHIC g573964g85h57.jpg GRAPHIC 43168
  Complete submission text file 0001193125-18-134950.txt   825382
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-224418 | Film No.: 18779130
SIC: 2836 Biological Products, (No Diagnostic Substances)